The article entitled aEURoePhase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent,aEUR was published in the premier cancer journal, ...
9 Sep 2010, 05:09:am
Google
Atrium's vast expertise in medical device technologies for the treatment of coronary and vascular disease, chest trauma, hernia and soft tissue injury has ...
9 Sep 2010, 04:09:am
Google
Mark Adelman, MD: Chief of the Division of Vascular Surgery and Endovascular Surgery, and Associate Professor of Surgery, NYU Langone Medical Center. ...
9 Sep 2010, 03:09:pm
Google
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records). A team of authors from the Mayo Clinic Divisions of ...
9 Sep 2010, 12:09:am
Yahoo
An emergency room nurse's curiosity about why some trauma patients develop sepsis while others don't has led to an expanded career as a researcher studying the question. Dr. Beth NeSmith, assistant professor of physiological and technological nursing in the Medical College of Georgia School of Nursing, has received a three-year, $281,000 National Institutes of Health grant to examine risk ...
9 Sep 2010, 12:09:am
Yahoo
Salvage of lower extremities following combined orthopedic and vascular trauma. A predictive salvage index. Am Surg . 1987; 53(4):205-208. ...
digg.com
Vascular injuries are a common underlying cause and require prompt recognition and a multidisciplinary approach including the trauma and orthopaedic ...
digg.com
In September 2008, the BARDA awarded us a contract under the BAA titled, "Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss, and Vascular ...
digg.com
Extracorporeal membrane oxygenation was initiated and sustained for 5 days The patient's course was complicated by peripheral vascular injury secondary to ...
digg.com
The article entitled aEURoePhase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent,aEUR was published in the premier cancer journal, ...
digg.com